MANNING MARTHA E

CIK 00012278943 companiesRADNOR, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001227894

Recent Transactions

41 trades

Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−74,468→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−75,000→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−57,900→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−98,250→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−57,500→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Common Stock
2025-02-11$0.55/sh−48,077→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2025-02-11−49,125→ 0 total
Disposition to Issuer
MARINUS PHARMACEUTICALS, INC.
Common Stock
2025-02-07$0.55/sh−12,186→ 48,077 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-08-05$1.13/sh−3,621→ 60,263 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2024-06-18+49,125→ 49,125 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-06-18+10,918→ 63,884 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-02-20$9.57/sh−1,894→ 52,966 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2024-01-18+98,250→ 98,250 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2024-01-18+21,835→ 54,860 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2023-08-08$8.93/sh−11→ 33,025 total
Sale
MARINUS PHARMACEUTICALS, INC.
Common Stock
2023-08-07$9.54/sh−2,169→ 33,036 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2023-01-26+16,548→ 35,205 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2023-01-26+74,468→ 74,468 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2022-05-24+5,790→ 18,657 total
Award
MARINUS PHARMACEUTICALS, INC.
Common Stock
2022-02-04+12,867→ 12,867 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2022-02-04+57,900→ 57,900 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock option (right to buy)
2021-01-15+57,500→ 57,500 total
Award
MARINUS PHARMACEUTICALS, INC.
Stock option (right to buy)
2020-06-15+300,000→ 300,000 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-29−135,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-29−110,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Common Stock
2020-01-28$6.30/sh−2,500→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−215,000→ 0 total
Disposition to Issuer
ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
2020-01-28−150,000→ 0 total
Award
ACHILLION PHARMACEUTICALS INC
Stock Option (Right to buy)
2019-01-23+150,000→ 150,000 total
Award
ACHILLION PHARMACEUTICALS INC
Employee Stock Option
2018-02-09+215,000→ 215,000 total
Award
ACHILLION PHARMACEUTICALS INC
Employee Stock Option
2017-01-17+135,000→ 135,000 total
Purchase
ACHILLION PHARMACEUTICALS INC
Common Stock
2016-12-02$4.09/sh+2,500→ 2,500 total
Award
ACHILLION PHARMACEUTICALS INC
Employee stock option
2016-02-01+110,000→ 110,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2008-01-04+40,000→ 40,000 total
Award
ADOLOR CORP
Deferred Stock
2007-06-13+5,000→ 5,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2007-06-13+40,000→ 40,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2006-01-06+40,000→ 40,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2005-01-06+50,000→ 50,000 total
Purchase
ADOLOR CORP
Common Stock
2004-05-27$13.75/sh+1,000→ 1,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2004-01-06+50,000→ 50,000 total
Award
ADOLOR CORP
Employee Stock Option (right to buy)
2003-10-27+5,000→ 5,000 total

Companies

Recent Filings

Address

5 RADNOR CORPORATE CENTER, SUITE 500 100 MATSONFORD RD

RADNOR, PA, 19087

View on SEC.gov